#PMPRB
Health Canada provides its quarterly update and PMPRB publishes the 10th edition of the Meds Entry Watch report
Health Canada provides its quarterly update and PMPRB publishes the 10th edition of the Meds Entry Watch report
On October 15, 2026, Health Canada provided its quarterly update summarizing steps it has taken “to make its regulatory processes more modern and...
www.jdsupra.com
October 29, 2026 at 8:08 PM
Canada's Patented Medicine Prices Review Board #PMPRB has released its Meds Entry Watch, 10th Edition www.canada.ca/content/dam/... 💊
October 15, 2026 at 1:11 AM
PMPRB consults further on revised proposed practice directions
PMPRB consults further on revised proposed practice directions
The Patented Medicine Prices Review Board (PMPRB) holds public hearings on two types of matters: to determine whether the price of a medicine is...
www.jdsupra.com
August 31, 2026 at 5:40 PM
PMPRB consults further on revised proposed practice directions
PMPRB consults further on revised proposed practice directions
The Patented Medicine Prices Review Board (PMPRB) holds public hearings on two types of matters: to determine whether the price of a medicine is...
www.jdsupra.com
August 31, 2026 at 5:40 PM
Report calls for changes to government’s interaction with drug-pricing board, pharmaceutical industry: Other recommendations in the House of Commons report include a call for the government to spell out the mandate of the PMPRB and for Ottawa to review how it enacts drug price regulatory reforms
Report calls for changes to government’s interaction with drug-pricing board, pharmaceutical industry
Other recommendations in the House of Commons report include a call for the government to spell out the mandate of the PMPRB and for Ottawa to review how it enacts drug price regulatory reforms
www.theglobeandmail.com
May 7, 2024 at 11:29 PM
I spent the last hour watching PMPRB testimony from this week. This is fascinating stuff. One opening statement lobs a grenade at patient groups funded by Pharma, basically accusing them of being mouthpieces as a result. I struggle with that a bit. 1/n
June 18, 2025 at 3:27 PM
Some of the more recent reports, for those who are following along. Feel free to add links:

May 2015: CORD’s National #raredisease Strategy:

June 2016: PMPRB Guidelines Modernization – Discussion Paper:
June 17, 2025 at 8:44 PM
Want to learn about proposed changes to the Patented Medicine Prices Review Board (PMPRB)? This report is co-authored by Chair of the @raredisorders Board of Directors, the incomparable @waynedcritchley.
June 17, 2025 at 6:44 PM
PMPRB finds price of Soliris was/is excessive & orders @AlexionPharma to pay gov & lower price. Learn: @AHUSCanada &
June 17, 2025 at 5:08 PM
PMPRB is the Patented Medicine Prices Review Board, whose job it is to make sure industry doesn't over-charge for patented drugs. They're a quasi-judicial body like the tax court, but for drug prices.

Worth reading up on them, I think it would help your idea solidify: www.canada.ca/en/patented-...
Patented Medicine Prices Review Board - Canada.ca
The Patented Medicine Prices Review Board (PMPRB) protects and informs Canadian consumers by ensuring that the prices of patented medicines sold in Canada are not excessive, and by reporting on pharma...
www.canada.ca
June 29, 2025 at 6:22 PM
Yeah, I'm Canadian. I'm aware of the threat from the US thanks, a quick scroll through my profile would have told you that.

Cancelling patents isn't the way to do this. Leverage the PMPRB to control patented drug prices while standing up this Crown Corp and then let them patent their own drugs
June 29, 2025 at 6:10 PM
It sounds like a good idea, right?

Unfortunately the cost of standing up a public drug manufacturer is insane. The reputational cost to Canada of cancelling patents would also be terrible.

Besides, Canada's mechanism for controlling patented drug prices is the PMPRB. Leverage them better instead.
June 29, 2025 at 4:53 PM
PMPRB consults on proposed Practice Directions for PMPRB hearings
PMPRB consults on proposed Practice Directions for PMPRB hearings
On March 5, 2026, the PMPRB published seven proposed Practice Directions aiming to provide clarity on procedural matters related to these...
www.jdsupra.com
March 27, 2026 at 7:00 PM
New PMPRB Chairperson and PMPRB releases January 2026 NEWSletter
New PMPRB Chairperson and PMPRB releases January 2026 NEWSletter
On January 29, 2026, the Minister of Health announced Anie Perrault, former Vice-Chairperson, as Chairperson of the Patented Medicine Prices...
www.jdsupra.com
February 24, 2026 at 8:10 PM
PMPRB update: Guidelines for PMPRB Staff come into effect January 1, 2026; 2024 Annual Report
PMPRB update: Guidelines for PMPRB Staff come into effect January 1, 2026; 2024 Annual Report
On January 1, 2026, the Guidelines for PMPRB Staff will come into effect. In November, the Patented Medicine Prices Review Board (PMPRB) held...
www.jdsupra.com
December 19, 2025 at 8:55 PM
Updated PMPRB Guidelines expected in summer 2025 and NPDUIS releases ninth edition of the Meds Entry Watch Report
Updated PMPRB Guidelines expected in summer 2025 and NPDUIS releases ninth edition of the Meds Entry Watch Report
In the Patented Medicine Prices Review Board (PMPRB)’s June 2025 NEWSletter, Acting Chairperson Anie Perrault confirms that the PMPRB plans on...
www.jdsupra.com
July 1, 2025 at 7:08 PM
New PMPRB Draft Guidelines outline administrative process for excessive price hearing recommendations
New PMPRB Draft Guidelines outline administrative process for excessive price hearing recommendations
As we previously reported, on December 19, 2024, the Patented Medicine Prices Review Board (PMPRB) released its Draft Guidelines for PMPRB Staff...
www.jdsupra.com
January 29, 2025 at 7:57 PM
PMPRB releases May NEWSLetter and Meds Pipeline Monitor
PMPRB releases May NEWSLetter and Meds Pipeline Monitor
On May 12, 2026, the Patented Medicine Prices Review Board (PMPRB) released its May NEWSLetter. The NEWSletter provides updates on the...
www.jdsupra.com
May 29, 2026 at 5:23 PM
PMPRB consults on proposed Practice Directions for PMPRB hearings
PMPRB consults on proposed Practice Directions for PMPRB hearings
On March 5, 2026, the PMPRB published seven proposed Practice Directions aiming to provide clarity on procedural matters related to these...
www.jdsupra.com
March 27, 2026 at 7:00 PM
New PMPRB Chairperson and PMPRB releases January 2026 NEWSletter
New PMPRB Chairperson and PMPRB releases January 2026 NEWSletter
On January 29, 2026, the Minister of Health announced Anie Perrault, former Vice-Chairperson, as Chairperson of the Patented Medicine Prices...
www.jdsupra.com
February 24, 2026 at 8:10 PM
PMPRB update: Guidelines for PMPRB Staff come into effect January 1, 2026; 2024 Annual Report
PMPRB update: Guidelines for PMPRB Staff come into effect January 1, 2026; 2024 Annual Report
On January 1, 2026, the Guidelines for PMPRB Staff will come into effect. In November, the Patented Medicine Prices Review Board (PMPRB) held...
www.jdsupra.com
December 19, 2025 at 8:55 PM
PMPRB releases Annual Public Drug Plan Expenditure Report (2022/23)
PMPRB releases Annual Public Drug Plan Expenditure Report (2022/23)
On October 21, 2025, the Patented Medicine Prices Review Board (PMPRB) announced the release of CompassRx (10th edition), an annual report that...
www.jdsupra.com
October 29, 2025 at 8:06 PM
Updated PMPRB Guidelines expected in summer 2025 and NPDUIS releases ninth edition of the Meds Entry Watch Report
Updated PMPRB Guidelines expected in summer 2025 and NPDUIS releases ninth edition of the Meds Entry Watch Report
In the Patented Medicine Prices Review Board (PMPRB)’s June 2025 NEWSletter, Acting Chairperson Anie Perrault confirms that the PMPRB plans on...
www.jdsupra.com
July 1, 2025 at 7:08 PM